WallStSmart
RLMD

Relmada Therapeutics Inc

NASDAQ: RLMD · HEALTHCARE · BIOTECHNOLOGY

$7.52
+2.04% today

Updated 2026-04-30

Market cap
$759.40M
P/E ratio
P/S ratio
9,001.90x
EPS (TTM)
$-1.45
Dividend yield
52W range
$0 – $8
Volume
2.1M

Relmada Therapeutics Inc (RLMD) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201220132014201420152016201720182019202020212022202320242025
Operating cash flow$-7565.00$-11859.00$-2.24M$-16.23M$-16.23M$-13.14M$-6.47M$-6.00M$-12092.00$-27.81M$-91.87M$-103.80M$-51.66M$-51.76M$-45.79M
Capital expenditures$0.00$1800.00$10000.00$23326.00$23326.00$562256.00$49690.00$12391.00$0.00$0.00$5.00$3.00$4.00$0.00$0.00
Depreciation$250.00$2703.00$9256.00$9256.00$54819.00$85271.00$2627.00$4.00$3752.00$1258.00$0.00
Stock-based comp$14477.00$1.98M$796952.00$1.21M$704452.00$518000.00$2761.00$20.78M$40.49M$44.19M$43.81M$30.19M$14.96M
Free cash flow$-7565.00$-13659.00$-2.25M$-16.25M$-16.25M$-13.71M$-6.52M$-6.01M$-12092.00$-27.81M$-91.87M$-103.80M$-51.66M$-51.76M$-45.79M
Investing cash flow$-1800.00$-12544.00$-23326.00$-23326.00$-562256.00$-49690.00$-12391.00$-80164.00$-34.45M$-54.12M$19.73M$50.45M$51.56M
Financing cash flow$13500.00$20000.00$4.00M$13.16M$13.16M$-263752.00$-273670.00$6.54M$126109.00$28.47M$187.94M$45.02M$-98463.00$-40341.00
Dividends paid
Share repurchases
Debt repayment
Net change in cash$6341.00$-3.09M$-13.97M$-6.79M$528431.00$6.98M$-39.05M